Adelaide Research & Scholarship: Search

Search

Results 51-60 of 72 (Search time: 0.002 seconds).

previous
1
...
3
4
5
6
7
8
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2015	A phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinoma	Pal, S.; Azad, A.; Bhatia, S.; Drabkin, H.; Costello, B.; Sarantopoulos, J.; Kanesvaran, R.; Lauer, R.; Starodub, A.; Hauke, R.; Sweeney, C.; Hahn, N.; Sonpavde, G.; Richey, S.; Breen, T.; Kremmidiotis, G.; Leske, A.; Doolin, E.; Bibby, D.; Simpson, J.; et al.
	2014	SPINK1 protein expression and prostate cancer progression	Flavin, R.; Pettersson, A.; Hendrickson, W.; Fiorentino, M.; Finn, S.; Kunz, L.; Judson, G.; Lis, R.; Bailey, D.; Fiore, C.; Nuttall, E.; Martin, N.; Stack, E.; Penney, K.; Rider, J.; Sinnott, J.; Sweeney, C.; Sesso, H.; Fall, K.; Giovannucci, E.; et al.
	2015	TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets	Yeung, D.; Osborn, M.; White, D.; Branford, S.; Braley, J.; Herschtal, A.; Kornhauser, M.; Issa, S.; Hiwase, D.; Hertzberg, M.; Schwarer, A.; Filshie, R.; Arthur, C.; Kwan, Y.; Trotman, J.; Forsyth, C.; Taper, J.; Ross, D.; Beresford, J.; Tam, C.; et al.
	2015	Aspirin, ibuprofen, and the risk of colorectal cancer in Lynch Syndrome	Ait Ouakrim, D.; Dashti, S.; Chau, R.; Buchanan, D.; Clendenning, M.; Rosty, C.; Winship, I.; Young, J.; Giles, G.; Leggett, B.; Macrae, F.; Ahnen, D.; Casey, G.; Gallinger, S.; Haile, R.; Le Marchand, L.; Thibodeau, S.; Lindor, N.; Newcomb, P.; Potter, J.; et al.
	2015	Fibrosis, gene expression and orbital inflammatory disease	Rosenbaum, J.; Choi, D.; Wilson, D.; Grossniklaus, H.; Harrington, C.; Dailey, R.; Ng, J.; Steele, E.; Czyz, C.; Foster, J.; Tse, D.; Alabiad, C.; Dubovy, S.; Parekh, P.; Harris, G.; Kazim, M.; Patel, P.; White, V.; Dolman, P.; Edward, D.; et al.
	2016	Health in times of uncertainty in the eastern Mediterranean region, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013	Mokdad, A.; Forouzanfar, M.; Daoud, F.; El Bcheraoui, C.; Moradi-Lakeh, M.; Khalil, I.; Afshin, A.; Tuffaha, M.; Charara, R.; Barber, R.; Wagner, J.; Cercy, K.; Kravitz, H.; Coates, M.; Robinson, M.; Estep, K.; Steiner, C.; Jaber, S.; Mokdad, A.; O'Rourke, K.; et al.
	2011	Apixaban versus Warfarin in patients with atrial fibrillation	Granger, C.; Alexander, J.; McMurray, J.; Lopes, R.; Hylek, E.; Hanna, M.; Al-Khalidi, H.; Ansell, J.; Avezum, A.; Atar, D.; Bahit, M.; Diaz, R.; Easton, J.; Ezekowitz, J.; Garcia, D.; Geraldes, M.; Gersh, B.; Golitsyn, S.; Goto, S.; Hermosillo, A.; et al.
	2016	Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes	Machiela, M.; Lan, Q.; Slager, S.; Vermeulen, R.; Teras, L.; Camp, N.; Cerhan, J.; Spinelli, J.; Wang, S.; Nieters, A.; Vijai, J.; Yeager, M.; Wang, Z.; Ghesquières, H.; McKay, J.; Conde, L.; de Bakker, P.; Cox, D.; Burdett, L.; Monnereau, A.; et al.
	2011	SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemia	Esposito, N.; Colavita, I.; Quintarelli, C.; Sica, A.; Peluso, A.; Luciano, L.; Picardi, M.; Vecchio, L.; Buonomo, T.; Hughes, T.; White, D.; Radich, J.; Russo, D.; Branford, S.; Saglio, G.; Vaz de Melo, J.; Martinelli, R.; Ruoppolo, M.; Kalebic, T.; Martinelli, G.; et al.
	2015	Analysis of KRAS/NRAS mutations in a phase III study of panitumumab with FOLFIRI compared with FOLFIRI zlone as second-line treatment for metastatic colorectal cancer	Peeters, M.; Oliner, K.; Price, T.; Cervantes, A.; Sobrero, A.; Ducreux, M.; Hotko, Y.; André, T.; Chan, E.; Lordick, F.; Punt, C.; Strickland, A.; Wilson, G.; Ciuleanu, T.; Roman, L.; Van Cutsem, E.; He, P.; Yu, H.; Koukakis, R.; Terwey, J.; et al.